Opexa Therapeutics (OPXA) Stock Gets Crushed: Can They Survive?

[adrotate group=”5″] Opexa Therapeutics Inc (NASDAQ: OPXA) Investors in Opexa Therapeutics were crushed on Friday, with the stock tumbling more than 69% on enormous volume, settling at $1.05 a share, a level not seen since the company implemented a 1:8 reverse stock split in 2015. Incidentally, the volume traded on Friday is roughly equal to … Read more

Biotechs Making A Comeback: Novavax (NVAX), Horizon Pharma (HZNP), Opexa Therapeutics (OPXA), Gilead Sciences (GILD), Valeant Pharmaceuticals (VRX)

The US stock market has taken a beating recently, with biotechs taking the brunt of the punishment after comments made by Hillary Clinton. However, today is a relatively green day across the board, and there are several biotech stocks that are making a comeback. Here are 5 biotechs that are making a comeback that’s well … Read more

Biggest Gainers In Biotech Today | CIGNA Corporation (CI) | Anthera Pharmaceuticals (ANTH) | ZIOPHARM Oncology (ZIOP) | Opexa Therapeutics (OPXA)

While this morning was a bit of a rough start for biotech stocks, it seems as though things are changing rather quickly from red to green. In the space, there are several stocks gaining, but I’ve dug out what are some of the biggest gainers so far today. Here’s the scoop… CIGNA Corporation Climbs On … Read more

Biotech Stock Opportunities | Aoxing Pharmaceutical Company (AXN) | Opexa Therapeutics (OPXA) | Gilead Sciences (GILD) | Galena Biopharma (GALE)

Today is a relatively interesting day for the biotech world; and looking at the stocks in the space, there are several possibly profitable opportunities starting to emerge. With that said, today we’re going to look at the 4 different biotech stocks that I think are presenting the largest opportunities at the moment. Here’s what I … Read more

Biotech Movers Today | Opexa Therapeutics (OPXA) | OncoGenex Pharmaceuticals (OGXI) | Acura Pharmaceuticals (ACUR) | Anthera Pharmaceuticals (ANTH) | BG Medicine (BGMD)

If you looked at the biotech space yesterday, you were looking at a sea of red. However, today, things are working out to be much different. There are several biotech stocks out there that are doing very well. With that said, here is a list of my top 5 biotech picks for the day. Watch … Read more

Opexa Hires Experienced Pharmaceutical Executive as Vice President of Business Development

THE WOODLANDS, Texas–(BUSINESS WIRE)– Opexa Therapeutics, Inc.(NASDAQ:OPXA), a biopharmaceutical company developing personalized immunotherapies for autoimmune disorders including multiple sclerosis (MS) and neuromyelitis optica (NMO), is pleased to announce that Dr. Jason Kralic has joined the company in the new role of Vice President of Business Development. Dr. Kralic will be responsible for business development activities, … Read more

Opexa Therapeutics (OPXA) Stock Gained More Than 20% Today!

Opexa Therapeutics Inc (NASDAQ: OPXA) This article was originally published at Warrior Trading News! Opexa Therapeutics is a clinical stage biopharma company that proved today that it’s getting closer and closer to a product launch. At the 2015 Microcap Conference, President and CEO of OPXA, Neil K. Warma gave a presentation that clearly excited investors. … Read more

Opexa Therapeutics (OPXA) Stock Climbs On CEO Presentation

Opexa Therapeutics Inc (NASDAQ: OPXA) Opexa Therapeutics stock is climbing today as a result of a presentation at the 2015 Marcum Microcap Conference that just wrapped up recently. In the presentation, OPXA CEO, Neil K. Warma announced financial information as well as information on the company’s pipeline and goals moving forward; and I have to … Read more